TMO — Thermo Fisher Scientific Inc
In 2026 Q2, 16 of the 140 tracked hedge funds reported a position in Thermo Fisher Scientific Inc (TMO), worth $246.97M combined. Over the quarter 10 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| VanEck | $155.42M | 0.09% | -10.3% |
| Polar Capital | $42.96M | 0.12% | +12.8% |
| North Growth | $16.03M | 2.10% | +18.5% |
| Duquesne | $9.63M | 0.22% | NEW |
| Quadrature | $7.71M | 0.07% | NEW |
| IMC | $5.78M | 0.05% | +28% |
| BOCHK | $4.46M | 0.70% | NEW |
| ARS | $1.38M | 0.06% | NO CHANGE |
| Caxton Associates | $863.34K | 0.02% | NEW |
| Ratan | $777.11K | 0.25% | NO CHANGE |
| Persistent | $619.18K | 0.20% | +145.5% |
| KRS | $597.23K | 0.28% | NO CHANGE |
| Polymer | $510.38K | 0.08% | +32.7% |
| Burr | $200.54K | 0.12% | -4.8% |
| Pingora | $30.08K | 0.02% | NO CHANGE |
| Barnes Dennig | $2.51K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.